Platelet aggregation pathway network-based approach for evaluating compounds efficacy

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Gu, Jiangyong ^a   Li, Qian ^a,b   Chen, Lirong ^a   Li, Youyong ^c   Hou, Tingjun ^c   Yuan, Gu ^a   Xu, Xiaojie ^a  

^a PEKING UNIVERSITY   (China)

^b INSTITUTE OF CHEMISTRY   (China)

^c SOOCHOW UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

3 (3,4 DIHYDROXYPHENYL)LACTIC ACID; ADENYLATE CYCLASE; ANTITHROMBOCYTIC AGENT; CHLOROGENIC ACID; CHRYSIN; DEOXYCHOLIC ACID; DIPYRIDAMOLE; FIBRINOGEN RECEPTOR; HERBACEOUS AGENT; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; PAPAVERINE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 4,5 BISPHOSPHATE PHOSPHODIESTERASE; PHOSPHOLIPASE A2; PROSTAGLANDIN G; PROTEIN KINASE C; PROTEINASE ACTIVATED RECEPTOR 1; PROTEINASE ACTIVATED RECEPTOR 4; PURINERGIC P2X RECEPTOR; PURINERGIC P2Y RECEPTOR; QUERCETIN; RHAPONTIN; RHEIN; SCUTELLARIN; SILIBININ; THROMBIN; THROMBOXANE A2 RECEPTOR; TIROFIBAN; UNINDEXED DRUG; WOGONIN;

AMINO ACID SEQUENCE; ARTICLE; CHINESE MEDICINE; MOLECULAR DOCKING; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION;

EID: 84877266544     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/425707     Document Type: Article

References (27)

1. Zerhouni E. A., Translational research: moving discovery to practice. Clinical Pharmacology and Therapeutics 2007 81 1 126 128 2-s2.0-33845978362 10.1038/sj.clpt.6100029 (Pubitemid 46050877)
2. Zhang K. X., Ouellette B. F., Pandora, a pathway and network discovery approach based on common biological evidence. Bioinformatics 2010 26 4 529 535 2-s2.0-77952318002
3. Pache R. A., Zanzoni A., Naval J., Mas J. M., Aloy P., Towards a molecular characterisation of pathological pathways. FEBS Letters 2008 582 8 1259 1265 2-s2.0-41149137043 10.1016/j.febslet.2008.02.014
4. Kitano H., Computational systems biology. Nature 2002 420 6912 206 210 2-s2.0-0037079054 10.1038/nature01254 (Pubitemid 35340131)
5. Keith C. T., Borisy A. A., Stockwell B. R., Multicomponent therapeutics for networked systems. Nature Reviews Drug Discovery 2005 4 1 71 78 2-s2.0-12144258457 10.1038/nrd1609 (Pubitemid 40109591)
6. Butcher E. C., Berg E. L., Kunkel E. J., Systems biology in drug discovery. Nature Biotechnology 2004 22 10 1253 1259 2-s2.0-5044226336 10.1038/nbt1017 (Pubitemid 39336778)
7. Kohl P., Crampin E. J., Quinn T. A., Noble D., Systems biology: an approach. Clinical Pharmacology and Therapeutics 2010 88 1 25 33 2-s2.0-77953811826 10.1038/clpt.2010.92
8. Henney A. M., Who will take up the gauntlet?: challenges and opportunities for systems biology and drug discovery. EMBO Reports 2009 10 1 S9 S13 2-s2.0-68049092169 10.1038/embor.2009.132
9. Arrell D. K., Terzic A., Network systems biology for drug discovery. Clinical Pharmacology and Therapeutics 2010 88 1 120 125 2-s2.0-77953811662 10.1038/clpt.2010.91
10. Janga S. C., Tzakos A., Structure and organization of drug-target networks: insights from genomic approaches for drug discovery. Molecular BioSystems 2009 5 12 1536 1548 2-s2.0-72949101438 10.1039/b908147j
11. Hopkins A. L., Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology 2008 4 11 682 690 2-s2.0-54249155522 10.1038/nchembio.118
12. Schadt E. E., Friend S. H., Shaywitz D. A., A network view of disease and compound screening. Nature Reviews Drug Discovery 2009 8 4 286 295 2-s2.0-64049085062 10.1038/nrd2826
13. Agoston V., Csermely P., Pongor S., Multiple weak hits confuse complex systems: a transcriptional regulatory network as an example. Physical Review E 2005 71 5 1 7 2-s2.0-26944477318 10.1103/PhysRevE.71.051909 051909 (Pubitemid 41480972)
14. Li Q., Li X., Li C., Chen L., Song J., Tang Y., Xu X., A network-based multi-target computational estimation scheme for anticoagulant activities of compounds. PLoS ONE 2011 6 3 2-s2.0-79952975593 10.1371/journal.pone.0014774 e14774
15. Xiang Y. Z., Kang L. Y., Gao X. M., Shang H. C., Zhang J. H., Zhang B. L., Strategies for antiplatelet targets and agents. Thrombosis Research 2008 123 1 35 49 2-s2.0-54049147727 10.1016/j.thromres.2008.05.003
16. Broos K., De Meyer S. F., Feys H. B., Blood platelet biochemistry. Thrombosis Research 2012 129 3 245 249
17. Jackson S. P., Schoenwaelder S. M., Antiplatelet therapy: in search of the 'magic bullet'. Nature Reviews Drug Discovery 2003 2 10 775 789 2-s2.0-0242300217 (Pubitemid 37361810)
18. Xiang Y. Z., Xia Y., Gao X. M., Shang H. C., Kang L. Y., Zhang B. L., Platelet activation, and antiplatelet targets and agents: current and novel strategies. Drugs 2008 68 12 1647 1664 2-s2.0-49249127272 10.2165/00003495- 200868120-00004
19. Sangkuhl K., Shuldiner A. R., Klein T. E., Altman R. B., Platelet aggregation pathway. Pharmacogenetics and Genomics 2011 21 8 516 521 2-s2.0-79960836902 10.1097/FPC.0b013e3283406323
20. Joshi-Tope G., Gillespie M., Vastrik I., D'Eustachio P., Schmidt E., de Bono B., Jassal B., Gopinath G. R., Wu G. R., Matthews L., Lewis S., Birney E., Stein L., Reactome: a knowledgebase of biological pathways. Nucleic Acids Research 2005 33 D428 D432 2-s2.0-13444259844 10.1093/nar/gki072 (Pubitemid 40207909)
21. Kanehisa M., Goto S., Furumichi M., Tanabe M., Hirakawa M., KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Research 2009 38 1 D355 D360 2-s2.0-75549090213 10.1093/nar/gkp896 gkp896
22. Jiang X., Kumar K., Hu X., Wallqvist A., Reifman J., DOVIS 2.0: an efficient and easy to use parallel virtual screening tool based on AutoDock 4.0. Chemistry Central Journal 2008 2 1, article 18 2-s2.0-52249109585 10.1186/1752-153X-2-18
23. Park H., Lee J., Lee S., Critical assessment of the automated AutoDock as a new docking tool for virtual screening. Proteins: Structure, Function and Genetics 2006 65 3 549 554 2-s2.0-33750083590 10.1002/prot.21183 (Pubitemid 44583206)
24. Latora V., Marchiori M., Efficient behavior of small-world networks. Physical Review Letters 2001 87 19 1 4 2-s2.0-35348957264 198701
25. Csermely P., Ágoston V., Pongor S., The efficiency of multi-target drugs: the network approach might help drug design. Trends in Pharmacological Sciences 2005 26 4 178 182 2-s2.0-15044349115 10.1016/j.tips.2005.02.007 (Pubitemid 40432652)
26. Spiro Z., Kovacs I. A., Csermely P., Drug-therapy networks and the prediction of novel drug targets. Journal of Biology 2008 7 6, article 20 2-s2.0-54249083832 10.1186/jbiol81
27. Xu X., New concepts and approaches for drug discovery based on traditional Chinese medicine. Drug Discovery Today 2006 3 3 247 253 2-s2.0-33750935268 10.1016/j.ddtec.2006.09.008 (Pubitemid 44734730)